Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Sep 1;40(9):e356.
doi: 10.1097/INF.0000000000003214.

Sinus Bradycardia in Children Treated With Remdesivir for COVID-19

Irini Eleftheriou  1 , Marianthi Liaska, Panagiotis Krepis, Foteini Dasoula, Dimitra Dimopoulou, Nikos Spyridis, Maria Tsolia
Affiliations
Comment

Sinus Bradycardia in Children Treated With Remdesivir for COVID-19

Irini Eleftheriou et al. Pediatr Infect Dis J. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors have no funding or conflicts of interest to disclose.

Comment in

Comment on

References

    1. COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. National Institutes of Health. Available at: https://www.covid19treatmentguidelines.nih.gov/ . Accessed March 5, 2021
    1. Beigel JH, Tomashek KM, Dodd LE.Remdesivir for the treatment of Covid-19 - preliminary report. Reply N Engl J Med. 2020;383:1813–1826
    1. Gubitosa JC, Kakar P, Gerula C, et al. Marked sinus bradycardia associated with remdesivir in COVID-19: a case and literature review JACC Case Rep. 2020;18:2260–2264
    1. Sanchez-Codez MI, Rodriguez-Gonzalez M, Gutierrez-Rosa I.Severe sinus bradycardia associated with Remdesivir in a child with severe SARS-CoV-2 infection Eur J Pediatr. 2021;23:1
    1. Touafchia A, Bagheri H, Carrié D, et al. Serious bradycardia and remdesivir for coronavirus 2019 (COVID-19): a new safety concerns Clin Microbiol Infect. 2021;26:S1198-743X(21)00094-X

LinkOut - more resources